GENinCode (LON:GENI) Announces Quarterly Earnings Results

GENinCode (LON:GENI) posted its quarterly earnings data on Tuesday. The company reported GBX (0.38) EPS for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 481.34% and a negative net margin of 202.42%.

GENinCode Stock Up 4.3%

Shares of GENI stock traded up GBX 0.03 during trading hours on Friday, hitting GBX 0.73. 2,466,655 shares of the company’s stock traded hands, compared to its average volume of 5,097,214. The stock’s fifty day simple moving average is GBX 0.88 and its two-hundred day simple moving average is GBX 0.98. GENinCode has a 12-month low of GBX 0.64 and a 12-month high of GBX 4.90. The stock has a market cap of £5.50 million, a price-to-earnings ratio of -0.35 and a beta of 0.59. The company has a quick ratio of 15.88, a current ratio of 2.22 and a debt-to-equity ratio of 4.75.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.